Alternatives to ReVision Implant

Developing ultra-high bandwidth brain-machine interfaces to connect humans and computers.

OptoCeutics develops non-invasive light-based technology to stimulate the brain and improve cognitive function.

Develops a brain-computer interface for treating epilepsy.

Neurolief develops proprietary digital therapeutics neuromodulation technology to treat neurological and neuropsychiatric disorders like migraine and depression.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

NeuroTech company developing therapies to restore movement and independence for people with spinal cord injuries.

Developing soft, stretchable brain-computer interface platforms.

Neurotechnology company developing real-time nervous system regulation tools using science-based audio.

Developing wearable brain imaging systems using quantum sensing technology.

Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.

Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.

Revolutionizing electrophysiology with innovative, wireless, wearable Smart Skin technology for advanced monitoring.

Motion-based driver monitoring using unconscious muscular submovements to detect cognitive state.

Develops and commercializes minimally invasive robotic platforms for the neuroscience field.

Non-invasive brain measurement technology for accessible brain health insights.

Developing a brain-computer interface for high-bandwidth neural data acquisition and stimulation.

Self-powered nanogenerator implanted to restore touch sensation by stimulating sensory nerves.

Provides accessible, real-time brain data and insights for research and innovation.

Brain-computer interface for restoring communication and mobility for people with paralysis.

Develops non-intrusive brain-based technology for enhanced human-to-machine and human-to-human communication.

Digital pathology imaging technology and AI-driven precision pathology software.

Neasensory develops wearable neurotechnology that translates sensory information into haptic feedback, enhancing human perception and aiding individuals with sensory impairments.

Develops advanced brain-computer interfaces (BCIs) to restore function and independence for individuals with neurological disorders.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

AI software solutions connecting people and technology via wearables and biosensors, transforming sensory data into actionable insights.

Epitel develops AI-driven wireless brain health technologies for remote EEG monitoring, improving diagnosis and management of neurological conditions like epilepsy.

Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.

Develops advanced brain-computer interfaces for neurological disorder treatment.

Bioelectric medicine company advancing neurorecovery for stroke and neurological conditions.

Integrated life science company specializing in diagnostic testing solutions and life science raw materials.

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

Redefining kidney stone treatment with an aspiration-based stone removal system.

Develops in-vitro diagnostic platforms for rapid antimicrobial susceptibility testing.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Pioneering neuro-endovascular surgical robotics for precise, remote-controlled treatment of brain aneurysms and strokes.

Dopl Technologies is a medical technology company developing a robotic ultrasound platform to expand access to diagnostic imaging in underserved communities.

Developing a minimally invasive, one-time outpatient therapy for obesity treatment.

Revolutionizing the treatment of thromboembolic disease through innovative medical technology and connected care solutions.

AI-powered breast cancer detection and risk assessment solutions.

Developing innovative, minimally invasive solutions for tricuspid valve disease treatment.

Developing ultrasound-mediated nonviral genetic medicines.

Pioneering vision restoration therapies for severe retinal degenerations.

Neurotechnology company analyzing brain signals from consumer headwear for real-time mind measurement.

A medical device company offering a comprehensive, swallowable gastric balloon program for weight loss.

Revolutionizing genomic analysis with innovative sequencing technology.

Developing advanced vision restoration technology through a retinal implant.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

Multisensory belt using touch stimuli to help people regain normal walking sensations.

Pioneering transcatheter technology for tricuspid regurgitation with a novel cross-caval approach.

Developing lightweight bionic technology.

A global pure-play dermatology company focused on injectable aesthetics, dermatological skincare, and therapeutic medicine.

Develops, manufactures, and markets radiopharmaceuticals for diagnostic and therapeutic applications.

Developing advanced diagnostic technology to expand global access to healthcare.

Developing a novel therapeutic approach for Alzheimer's disease.

Continuous neurological monitoring wearable for hospitals, rehab, and home use.